Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Industry 2016 Deep Market Research Report
- QYR575889
- 177 Pages
- April 2016
- Diagnostic and Biotech
First, the report provides a basic overview of the Commercializing Biomarkers in Therapeutic and Diagnostic Applications industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.
Secondly, the report states the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed.
Third, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies.
Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications industry development trends and marketing channels are analyzed.
Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.
In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.1 Definition and Specifications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.1.1 Definition of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.1.2 Specifications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.2 Classification of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.3 Applications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.4 Industry Chain Structure of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.5 Industry Overview and Major Regions Status of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.5.1 Industry Overview of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.5.2 Global Major Regions Status of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.6 Industry Policy Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.7 Industry News Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2 Manufacturing Cost Structure Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.1 Raw Material Suppliers and Price Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.2 Equipment Suppliers and Price Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.3 Labor Cost Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.4 Other Costs Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.5 Manufacturing Cost Structure Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.6 Manufacturing Process Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
3 3 Global Market Size (Volume and Value), Sales and Sale Price Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
3.1 Global Market Size (Volume and Value) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
3.2 Global Market Size (Volume and Value) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions 2011-2016
3.3 Global Market Size (Volume and Value) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
3.4 Global Market Size (Volume and Value) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
3.5 Global Sales Volume and Sales Revenue of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
3.6 Global Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions 2011-2016
3.7 Global Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
3.8 Global Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
3.9 Global Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
4 United States Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
4.1 United States Market Size (Volume and Value) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
4.2 United States Market Size (Volume and Value) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
4.3 United States Market Size (Volume and Value) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
4.4 United States Sales Volume and Sales Revenue of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
4.5 United States Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
4.6 United States Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
4.7 United States Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
4.8 United States Regional Supply, Import, Export and Consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
4.9 United States End Users with Contact Information and Consumption Volume of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications
5 Europe Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
5.1 Europe Market Size (Volume and Value) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
5.2 Europe Market Size (Volume and Value) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
5.3 Europe Market Size (Volume and Value) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
5.4 Europe Sales Volume and Sales Revenue of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
5.5 Europe Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
5.6 Europe Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
5.7 Europe Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
5.8 Europe Regional Supply, Import, Export and Consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
5.9 Europe End Users with Contact Information and Consumption Volume of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications
6 China Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
6.1 China Market Size (Volume and Value) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
6.2 China Market Size (Volume and Value) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
6.3 China Market Size (Volume and Value) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
6.4 China Sales Volume and Sales Revenue of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
6.5 China Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
6.6 China Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
6.7 China Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
6.8 China Regional Supply, Import, Export and Consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
6.9 China End Users with Contact Information and Consumption Volume of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications
7 Japan Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
7.1 Japan Market Size (Volume and Value) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
7.2 Japan Market Size (Volume and Value) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
7.3 Japan Market Size (Volume and Value) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
7.4 Japan Sales Volume and Sales Revenue of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
7.5 Japan Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
7.6 Japan Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
7.7 Japan Sale Price of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
7.8 Japan Regional Supply, Import, Export and Consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
7.9 Japan End Users with Contact Information and Consumption Volume of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications
8 Major Manufacturers Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
8.1 Roche
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Capacity, Production, Price, Cost, Gross and Revenue
8.1.4 Contact Information
8.2 Dako (Agilent Technologies)
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Capacity, Production, Price, Cost, Gross and Revenue
8.2.4 Contact Information
8.3 Merck
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Capacity, Production, Price, Cost, Gross and Revenue
8.3.4 Contact Information
8.4 BD
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Capacity, Production, Price, Cost, Gross and Revenue
8.4.4 Contact Information
8.5 Abbott
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Capacity, Production, Price, Cost, Gross and Revenue
8.5.4 Contact Information
8.6 Genesys Biolabs(20/20GeneSystems)
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Capacity, Production, Price, Cost, Gross and Revenue
8.6.4 Contact Information
8.7 Affymetrix
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Capacity, Production, Price, Cost, Gross and Revenue
8.7.4 Contact Information
8.8 Agendia
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Type I
8.8.2.2 Type II
8.8.2.3 Type III
8.8.3 Capacity, Production, Price, Cost, Gross and Revenue
8.8.4 Contact Information
8.9 ALMAC
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Type I
8.9.2.2 Type II
8.9.2.3 Type III
8.9.3 Capacity, Production, Price, Cost, Gross and Revenue
8.9.4 Contact Information
8.10 Arrayit
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Type I
8.10.2.2 Type II
8.10.2.3 Type III
8.10.3 Capacity, Production, Price, Cost, Gross and Revenue
8.10.4 Contact Information
8.11 Biocartic
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.2.1 Type I
8.11.2.2 Type II
8.11.2.3 Type III
8.11.3 Capacity, Production, Price, Cost, Gross and Revenue
8.11.4 Contact Information
8.12 BG Medicine
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.2.1 Type I
8.12.2.2 Type II
8.12.2.3 Type III
8.12.3 Capacity, Production, Price, Cost, Gross and Revenue
8.12.4 Contact Information
8.13 KEGG EXPRESSION Database
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.2.1 Type I
8.13.2.2 Type II
8.13.2.3 Type III
8.13.3 Capacity, Production, Price, Cost, Gross and Revenue
8.13.4 Contact Information
8.14 Thermo Fisher
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.2.1 Type I
8.14.2.2 Type II
8.14.2.3 Type III
8.14.3 Capacity, Production, Price, Cost, Gross and Revenue
8.14.4 Contact Information
8.15 BGI
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.2.1 Type I
8.15.2.2 Type II
8.15.2.3 Type III
8.15.3 Capacity, Production, Price, Cost, Gross and Revenue
8.15.4 Contact Information
9 Global Production Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions
9.1 Global Production of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions 2011-2016
9.2 Global Production Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions 2011-2016
10 Global and Major Regions Market Size (Volume and Value) Forecast of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
10.1 Global and Major Regions Market Size (Volume and Value) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2016-2021
10.2 Global Market Size (Volume and Value) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions 2016-2021
10.3 Global and Major Regions Market Size (Volume and Value) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2016-2021
10.4 Global and Major Regions Market Size (Volume and Value) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2016-2021
11 Marketing Trader or Distributor Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
11.1 Marketing Channels Status of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
11.2 Traders or Distributors with Contact Information of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions
11.3 Regional Import, Export and Trade Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
12 New Project Investment Feasibility Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
12.1 New Project SWOT Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
12.2 New Project Investment Feasibility Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
13 Conclusion of the Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption 2016 Market Research Report
Figure Picture of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table Product Specifications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table Classification of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Figure Global Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Figure Global Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table Applications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Figure Global Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Figure Global Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Figure Industry Chain Structure of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Major Companies
Table Global Major Regions Commercializing Biomarkers in Therapeutic and Diagnostic Applications Development Status
Table Industry Policy of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table Industry News List of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Table Raw Material Suppliers and Price Analysis
Table Equipment Suppliers and Price Analysis
Table Manufacturing Cost Structure Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications in 2015
Figure Manufacturing Process Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Figure Global Market Size (Volume) (K Units) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
Figure Global Market Size (Value) (M USD) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
Table Global Market Size (Volume) (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions 2011-2016
Figure Global Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions in 2011
Figure Global Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions in 2015
Table Global Market Size (Value) (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions 2011-2016
Figure Global Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions in 2011
Figure Global Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions in 2015
Table Global Market Size (Volume) (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure Global Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2011
Figure Global Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table Global Market Size (Value) (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure Global Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2011
Figure Global Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table Global Market Size (Volume) (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure Global Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2011
Figure Global Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table Global Market Size (Value) (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure Global Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2011
Figure Global Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table Global Sales Volume (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Table Global Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure Global Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2011
Figure Global Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Table Global Sales Revenue (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Table Global Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure Global Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2011
Figure Global Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Table Global Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions 2011-2016
Figure Global Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions in 2015
Table Global Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure Global Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table Global Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure Global Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table Global Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure Global Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Figure United States Market Size (Volume) (K Units) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
Figure United States Market Size (Value) (M USD) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
Table United States Market Size (Volume) (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure United States Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2011
Figure United States Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table United States Market Size (Value) (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure United States Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2011
Figure United States Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table United States Market Size (Volume) (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure United States Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2011
Figure United States Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table United States Market Size (Value) (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure United States Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2011
Figure United States Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table United States Sales Volume (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Table United States Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure United States Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2011
Figure United States Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Table United States Sales Revenue (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Table United States Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure United States Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2011
Figure United States Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Figure United States Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure United States Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table United States Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure United States Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table United States Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure United States Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Table United States Regional Supply, Import, Export and Consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016 (K Units)
Table United States End Users with Contact Information and Consumption Volume of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications
Figure Europe Market Size (Volume) (K Units) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
Figure Europe Market Size (Value) (M USD) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
Table Europe Market Size (Volume) (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure Europe Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2011
Figure Europe Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table Europe Market Size (Value) (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure Europe Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2011
Figure Europe Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table Europe Market Size (Volume) (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure Europe Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2011
Figure Europe Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table Europe Market Size (Value) (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure Europe Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2011
Figure Europe Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table Europe Sales Volume (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Table Europe Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure Europe Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2011
Figure Europe Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Table Europe Sales Revenue (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Table Europe Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure Europe Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2011
Figure Europe Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Figure Europe Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure Europe Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table Europe Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure Europe Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table Europe Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure Europe Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Table Europe Regional Supply, Import, Export and Consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016 (K Units)
Table Europe End Users with Contact Information and Consumption Volume of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications
Figure China Market Size (Volume) (K Units) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
Figure China Market Size (Value) (M USD) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
Table China Market Size (Volume) (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure China Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2011
Figure China Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table China Market Size (Value) (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure China Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2011
Figure China Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table China Market Size (Volume) (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure China Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2011
Figure China Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table China Market Size (Value) (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure China Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2011
Figure China Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table China Sales Volume (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Table China Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure China Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2011
Figure China Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Table China Sales Revenue (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Table China Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure China Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2011
Figure China Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Figure China Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure China Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table China Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure China Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table China Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure China Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Table China Regional Supply, Import, Export and Consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016 (K Units)
Table China End Users with Contact Information and Consumption Volume of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications
Figure Japan Market Size (Volume) (K Units) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
Figure Japan Market Size (Value) (M USD) and Growth Rate of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016
Table Japan Market Size (Volume) (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure Japan Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2011
Figure Japan Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table Japan Market Size (Value) (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure Japan Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2011
Figure Japan Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table Japan Market Size (Volume) (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure Japan Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2011
Figure Japan Market Size (Volume) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table Japan Market Size (Value) (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure Japan Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2011
Figure Japan Market Size (Value) Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table Japan Sales Volume (K Units) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Table Japan Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure Japan Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2011
Figure Japan Sales Volume Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Table Japan Sales Revenue (M USD) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Table Japan Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure Japan Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2011
Figure Japan Sales Revenue Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Figure Japan Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types 2011-2016
Figure Japan Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2015
Table Japan Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications 2011-2016
Figure Japan Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications in 2015
Table Japan Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies 2011-2016
Figure Japan Sale Price (USD/Unit) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Companies in 2015
Table Japan Regional Supply, Import, Export and Consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016 (K Units)
Table Japan End Users with Contact Information and Consumption Volume of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Applications
Table Roche Information List
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture and Specifications of Roche
Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units), Sales Revenue (M USD), Sale Price (USD/Unit) and Gross Margin of Roche 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Growth Rate of Roche 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Global Market Share of Roche 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Growth Rate of Roche 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Global Market Share of Roche 2011-2016
Table Dako (Agilent Technologies) Information List
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture and Specifications of Dako (Agilent Technologies)
Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units), Sales Revenue (M USD), Sale Price (USD/Unit) and Gross Margin of Dako (Agilent Technologies) 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Growth Rate of Dako (Agilent Technologies) 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Global Market Share of Dako (Agilent Technologies) 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Growth Rate of Dako (Agilent Technologies) 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Global Market Share of Dako (Agilent Technologies) 2011-2016
Table Merck Information List
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture and Specifications of Merck
Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units), Sales Revenue (M USD), Sale Price (USD/Unit) and Gross Margin of Merck 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Growth Rate of Merck 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Global Market Share of Merck 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Growth Rate of Merck 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Global Market Share of Merck 2011-2016
Table BD Information List
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture and Specifications of BD
Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units), Sales Revenue (M USD), Sale Price (USD/Unit) and Gross Margin of BD 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Growth Rate of BD 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Global Market Share of BD 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Growth Rate of BD 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Global Market Share of BD 2011-2016
Table Abbott Information List
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture and Specifications of Abbott
Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units), Sales Revenue (M USD), Sale Price (USD/Unit) and Gross Margin of Abbott 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Growth Rate of Abbott 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Global Market Share of Abbott 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Growth Rate of Abbott 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Global Market Share of Abbott 2011-2016
Table Genesys Biolabs(20/20GeneSystems) Information List
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture and Specifications of Genesys Biolabs(20/20GeneSystems)
Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units), Sales Revenue (M USD), Sale Price (USD/Unit) and Gross Margin of Genesys Biolabs(20/20GeneSystems) 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Growth Rate of Genesys Biolabs(20/20GeneSystems) 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Global Market Share of Genesys Biolabs(20/20GeneSystems) 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Growth Rate of Genesys Biolabs(20/20GeneSystems) 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Global Market Share of Genesys Biolabs(20/20GeneSystems) 2011-2016
Table Affymetrix Information List
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture and Specifications of Affymetrix
Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units), Sales Revenue (M USD), Sale Price (USD/Unit) and Gross Margin of Affymetrix 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Growth Rate of Affymetrix 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Global Market Share of Affymetrix 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Growth Rate of Affymetrix 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Global Market Share of Affymetrix 2011-2016
Table Agendia Information List
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture and Specifications of Agendia
Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units), Sales Revenue (M USD), Sale Price (USD/Unit) and Gross Margin of Agendia 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Growth Rate of Agendia 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Global Market Share of Agendia 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Growth Rate of Agendia 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Global Market Share of Agendia 2011-2016
Table ALMAC Information List
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture and Specifications of ALMAC
Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units), Sales Revenue (M USD), Sale Price (USD/Unit) and Gross Margin of ALMAC 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Growth Rate of ALMAC 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Global Market Share of ALMAC 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Growth Rate of ALMAC 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Global Market Share of ALMAC 2011-2016
Table Arrayit Information List
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture and Specifications of Arrayit
Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units), Sales Revenue (M USD), Sale Price (USD/Unit) and Gross Margin of Arrayit 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Growth Rate of Arrayit 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units) and Global Market Share of Arrayit 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Growth Rate of Arrayit 2011-2016
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Revenue (M USD) and Global Market Share of Arrayit 2011-2016
Table Biocartic Information List
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture and Specifications of Biocartic
Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Volume (K Units), Sales Revenue (M USD), Sale Price (USD/Un
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
